Indivior Pharmaceuticals Inc
INDV
Rangering i aksjer
#3882
Indivior Pharmaceuticals Inc. operates as a holding company, primarily engaged... Indivior Pharmaceuticals Inc. operates as a holding company, primarily engaged in the research, production, and distribution of buprenorphine-based prescription medications designed to treat opioid dependence. Its product lineup features key pharmaceuticals such as Suboxone Film, Suboxone Tablet, and Subutex Tablet. The company organizes its business into several geographical regions: the United States, the United Kingdom, and the broader international market. Established on September 26, 2014, its corporate headquarters are located in North Chesterfield, Virginia.
Aksjekurs
$34.01
Sist synkronisert: 2026-10-19
Markedsverdi
$4.24B
Endring (1 dag)
4.81%
Endring (1 år)
40.02%
Land
US
Handel Indivior Pharmaceuticals Inc (INDV)
Kategori
Healthcare
P/S-forhold for Indivior Pharmaceuticals Inc (INDV)
P/S-forhold per October 2026 TTM: 3.20
Ifølge Indivior Pharmaceuticals Inc sine siste finansielle rapporter og aksjekurs er selskapets nåværende P/S-forhold (TTM) 3.20. Ved slutten av 2023 hadde selskapet et P/S-forhold på 1.94.
P/S-historikk for Indivior Pharmaceuticals Inc fra 2016 til 2026
P/S-forhold ved hvert års slutt
| År | P/S-forhold | Endre |
|---|---|---|
| 2026 (TTM) | 3.20 | 131.87% |
| 2024 | 1.38 | -28.93% |
| 2023 | 1.94 | -43.14% |
| 2022 | 3.42 | 5.76% |
| 2021 | 3.23 | 106.90% |
| 2020 | 1.56 | 235.34% |
| 2019 | 0.47 | -54.45% |
| 2018 | 1.02 | -70.40% |
| 2017 | 3.45 | 30.98% |
| 2016 | 2.64 | 0.00% |
P/S-forhold for lignende selskaper eller konkurrenter
| Selskap | P/S-forhold | Forskjell i P/S-forhold | Land |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| 7.06 | 120.57% |
IN
|
